Dr. Mitchell Ford Peabody D.O.

Expert Publications

• Oxytocin receptor activity in the ventrocaudal periaqueductal gray modulates anxiety-related behavior in postpartum rats.
• GABA(A) receptor antagonism in the ventrocaudal periaqueductal gray increases anxiety in the anxiety-resistant postpartum rat.

Media Releases

Dr. Peabody is a hematologist-oncologist serving Tallahassee and the surrounding communities. He is associated with Tallahassee Memorial Healthcare – a private, not-for-profit community healthcare system committed to transforming care, advancing health, and improving lives with an ultimate vision to elevate the standards of our healthcare practice, quality and innovation in our region.

Dr. Peabody received his Doctor of Oncology (DO) from Michigan State University in 2009. He completed an internship at St. John Macomb hospital in 2010, his residency at Providence Hospital in 2012, and his fellowship at the same hospital in 2015. It was during his time he became specialized in hematology cncology and internal medicine.

Dr. Peabody is board-certified in hematology and medical oncology by the American Board of Internal Medicine. The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Oncology is a healthcare profession dedicated to the diagnosis and treatment of cancer. As on oncologist, Dr. Peabody diagnoses cancer through methods such as biopsy, endoscopy, X-ray, blood tests, ultrasound, and different forms of nuclear medicine. He will treat cancer through surgery, chemotherapy, radiotherapy, hormone therapy, or antibody treatments. If it is determined that a cancer cannot successfully be treated, he will then focus on providing palliative care, the use of pain medication to make a dying person more comfortable.

With 10 years of experience in the field, Dr. Peabody has treated thousands of patients.

Recommended Articles

• 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial

  When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...

• Survey Shows Lack of Blood Cancer Knowledge Among Americans

  If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...

• Roles of the National Coalition for Cancer Survivorship

  The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...

• Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery

  It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...

• Boy Who Donated Hair to Kids with Cancer Fights Stage Four Lymphoma

  Torrin Breneman first learned about cancer three years ago, and it made an impact on him. When he learned what cancer can do to a person, and that it affects children across the world, Torrin made a decision to do something about it. He grew out his hair for the next three years, with the intentions...

• How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma

  Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...